PLAINSBORO, N.J., Oct. 24, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the full U.S. market release of the Integra® Complete Cervical Intervertebral Body Fusion Device (IBD), expanding Integra’s spine product portfolio with the addition of a zero-profile, stand-alone IBD for anterior cervical decompression and fusion (ACDF) procedures. The Integra® Complete Cervical IBD has received 510(k) clearance from the United States Food & Drug Administration (FDA), and is designed to help provide stability for spinal fusion after a diseased cervical disc is surgically removed.
